Sirolimus in cardiac transplantation: Use as a primary immunosuppressant in calcineurin inhibitor-induced nephrotoxicity

Journal of Heart and Lung Transplantation

Volumn 24, Issue 12, 2005, Pages 2129-2136

  Kushwaha, Sudhir S ^a   Khalpey, Zain ^a   Frantz, Robert P ^a   Rodeheffer, Richard J ^a   Clavell, Alfredo L ^a   Daly, Richard C ^a   McGregor, Christopher G ^a   Edwards, Brooks S ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; AZATHIOPRINE; CALCINEURIN INHIBITOR; CYCLOSPORIN A; EZETIMIBE; FISH OIL; GEMFIBROZIL; IOTALAMIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PRAVASTATIN; PREDNISONE; RAPAMYCIN; SIMVASTATIN; STEROID; TACROLIMUS;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ADULT; AGED; ARTICLE; BLOOD TOXICITY; CARDIAC ALLOGRAFT VASCULOPATHY; CARDIAC GRAFT REJECTION; CLINICAL ARTICLE; CONTROLLED STUDY; DIARRHEA; DIGESTIVE SYSTEM FUNCTION DISORDER; DISEASE EXACERBATION; DRUG SUBSTITUTION; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART FUNCTION; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; MALE; MOUTH ULCER; NEPHROTOXICITY; PERIPHERAL EDEMA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECIPIENT; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; TIME SERIES ANALYSIS; TITRIMETRY; TREATMENT WITHDRAWAL; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; CALCINEURIN; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY DISEASES; MALE; MIDDLE AGED; RISK FACTORS; SIROLIMUS;

EID: 29144480970     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2005.08.015     Document Type: Article

References (31)

1. A.H. Wilkinson, D.J. Cohen Renal failure in the recipients of nonrenal solid organ transplants J Am Soc Nephrol 10 1999 1136 1144
2. T.F. Andoh, E.A. Burdmann, W.M. Bennett Nephrotoxicity of immunosuppressive drugs experimental and clinical observations Semin Nephrol 17 1997 34 45
3. W.M. Bennett Insights into chronic cyclosporine nephrotoxicity Int J Clin Pharmacol Ther 34 1996 515 519
4. T.F. Andoh, E.A. Burdmann, N. Fransechini, D.C. Houghton, W.M. Bennett Comparison of acute rapamycin nephrotoxicity with cyclosporine and FK506 Kidney Int 50 1996 1110 1117
5. A.O. Ojo, P.J. Held, F.K. Port Chronic renal failure after transplantation of a nonrenal organ N Engl J Med 349 2003 931 940
6. S.N. Sehgal, H. Baker, C. Vezina Rapamycin (AY-22989), a new antifungal antibiotic. II. Fermentation, isolation and characterization J Antibiot (Tokyo) 28 1975 727 732
7. C.G. Groth, L. Backman, J.M. Morales Sirolimus European Renal Transplant Study Group Sirolimus (rapamycin)-based therapy in human renal transplantation similar efficacy and different toxicity compared with cyclosporine Transplantation 67 1999 1036 1042
8. S.M. Flechner, S.M. Kurian, K. Solez De novo kidney transplantation without use of calcineurin inhibitors preserves renal structure and function at two years Am J Transplant 4 2004 1776 1785
9. D.M. Wilson, J.H. Bergert, T.S. Larson, R.R. Liedtke GFR determined by nonradiolabeled iothalamate using capillary electrophoresis Am J Kidney Dis 30 1997 646 652
10. D. Mancini, S. Pinney, D. Burkhoff Use of rapamycin slows progression of cardiac transplantation vasculopathy Circulation 108 2003 48 53
11. H.J. Eisen, E.M. Tuzcu, R. Dorent Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients N Engl J Med 349 2003 847 858
12. A. Keogh, M. Richardson, P. Ruygrok Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years a randomized clinical trial Circulation 110 2004 2694 2700
13. F.S. Shihab, W.M. Bennett, H. Yi, S.O. Choi, T.F. Andoh Sirolimus increases transforming growth factor-beta1 expression and potentiates chronic cyclosporine nephrotoxicity Kidney Int 65 2004 1262 1271
14. J.M. Morales, A. Andres, M. Rengel, J.L. Rodicio Influence of cyclosporin, tacrolimus and rapamycin on renal function and arterial hypertension after renal transplantation Nephrol Dial Transplant 16 2001 121 124
15. T.F. Andoh, J. Lindsley, N. Franceschini, W.M. Bennett Synergistic effects of cyclosporine and rapamycin in a chronic nephrotoxicity model Transplantation 62 1996 311 316
16. J. Groetzner, I. Kaczmarek, P. Landwehr Renal recovery after conversion to a calcineurin inhibitor-free immunosuppression in late cardiac transplant recipients Eur J Cardiothorac Surg 25 2004 333 341
17. J. Groetzner, I. Kaczmarek, B. Meiser Sirolimus and mycophenolate mofetil as calcineurin inhibitor-free immunosuppression in a cardiac transplant patient with chronic renal failure J Heart Lung Transplant 23 2004 770 773
18. J. Groetzner, B. Meiser, P. Landwehr Mycophenolate mofetil and sirolimus as calcineurin inhibitor-free immunosuppression for late cardiac-transplant recipients with chronic renal failure Transplantation 77 2004 568 574
19. N.E. Lobach, S.M. Pollock-Barziv, L.J. West, A.I. Dipchand Sirolimus immunosuppression in pediatric heart transplant recipients a single-center experience J Heart Lung Transplant 24 2005 184 189
20. K/DOQI clinical practice guidelines for chronic kidney disease evaluation, classification, and stratification Am J Kidney Dis 39 suppl 2002 S1 S266
21. D.R. Davies, I. Bittmann, J. Pardo Histopathology of calcineurin inhibitor-induced nephrotoxicity Transplantation 69 suppl 2000 SS11 SS13
22. G.I. Snell, B.J. Levvey, W. Chin Sirolimus allows renal recovery in lung and heart transplant recipients with chronic renal impairment J Heart Lung Transplant 21 2002 540 546
23. S.R. Inman, N.A. Davis, K.M. Olson Rapamycin preserves renal function compared with cyclosporine A after ischemia/reperfusion injury Urology 62 2003 750 754
24. Y. Tao, J. Kim, R.W. Schrier, C.L. Edelstein Rapamycin markedly slows disease progression in a rat model of polycystic kidney disease J Am Soc Nephrol 2004
25. C. Daniel, J. Pippin, S.J. Shankland, C. Hugo The rapamycin derivative RAD inhibits mesangial cell migration through the CDK-inhibitor p27KIP1 Lab Invest 84 2004 588 596
26. N. Frey, T. Barrientos, J.M. Shelton Mice lacking calsarcin-1 are sensitized to calcineurin signaling and show accelerated cardiomyopathy in response to pathological biomechanical stress Nat Med 10 2004 1336 1343
27. H. Valantine Cardiac allograft vasculopathy after heart transplantation risk factors and management J Heart Lung Transplant 23 suppl 2004 S187 S193
28. H. Eisen, H. Ross Optimizing the immunosuppressive regimen in heart transplantation J Heart Lung Transplant 23 suppl 2004 S207 S213
29. P.G. Dean, W.J. Lund, T.S. Larson Wound-healing complications after kidney transplantation a prospective, randomized comparison of sirolimus and tacrolimus Transplantation 77 2004 1555 1561
30. J. Groetzner, F. Kur, F. Spelsberg Airway anastomosis complications in de novo lung transplantation with sirolimus-based immunosuppression J Heart Lung Transplant 23 2004 632 638
31. H. Lehmkuhl, R. Hetzer Clinical experience with Certican (everolimus) in de novo heart transplant patients at the Deutsches Herzzentrum Berlin J Heart Lung Transplant 24 suppl 2005 S201 S205